Welcome to our dedicated page for Zoetis SEC filings (Ticker: ZTS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Zoetis Inc. (ZTS) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Zoetis, described as the world’s leading animal health company, uses filings such as Form 8-K to report material events related to its operations, financing activities, governance and shareholder returns.
Recent 8-K filings detail several types of information. Zoetis has reported the completion of a private offering of 0.25% Convertible Senior Notes due 2029, including the terms of the notes, their conversion features, optional redemption provisions and related capped call transactions. Other filings describe the issuance of senior notes due 2028 and 2035 under an existing indenture, as well as a revolving credit agreement that provides a senior unsecured revolving credit facility and replaces a prior credit agreement.
Filings also cover corporate actions affecting shareholders, such as declarations of cash dividends on Zoetis common stock and the use of proceeds from financing transactions to repurchase shares under an existing share repurchase program. Additional 8-Ks report quarterly financial results, guidance updates, and investor presentations, including an Innovation Webcast that outlines the company’s pipeline and strategic approach to addressing unmet medical needs in animals.
Through this page, users can review how Zoetis discloses information about its NYSE-listed common stock, debt obligations, credit facilities and board-level decisions. Stock Titan’s platform associates these filings with AI-powered tools that summarize key terms and highlight items such as note covenants, leverage provisions, dividend declarations and event-driven disclosures, helping readers interpret lengthy documents more efficiently.
Zoetis Inc. Chief Executive Officer and director Kristin C. Peck reported multiple equity transactions involving company stock and restricted stock units (RSUs). On February 6, 2026, RSU vesting led to the acquisition of 5,555 shares of common stock, followed by the disposition of 1,914 shares at $127.42 per share. On February 8, 2026, additional RSUs vested, generating 6,224 shares of common stock, with 2,722 shares disposed of at $127.42 per share.
After these transactions, Peck directly held 101,337 shares of Zoetis common stock and 833.6435 common stock equivalents in the Zoetis Savings Plan (401(k)) as of December 31, 2025, along with 22,062.8977 RSUs outstanding under the company’s equity incentive plan.
Zoetis Inc. declared a quarterly dividend of $0.53 per share for the second quarter of 2026. The dividend will be paid on June 2, 2026 to shareholders of record as of the close of business on April 20, 2026. The company also noted that the related information is being furnished under Regulation FD and not treated as filed for liability purposes.
Zoetis Inc. chief executive Kristin C. Peck reported an acquisition of 367.2079 phantom stock units on January 9, 2026, under the Zoetis Supplemental Savings Plan. These units are a form of deferred, cash-settled compensation whose value is tied to Zoetis common stock plus a small portion of cash-equivalent investments. After this transaction, Peck holds a total of 58,410.776 phantom stock units directly. Each unit represents a fraction of a phantom share of Zoetis common stock and typically includes around 5% of its value in cash-equivalent investments, so the total value moves with the Zoetis share price and the value of those cash-equivalent holdings.
Zoetis Inc. Executive Vice President Keith Sarbaugh reported an acquisition of derivative-based compensation tied to the company’s stock. On 01/09/2026, he acquired 149.604 phantom stock units under the Zoetis Supplemental Savings Plan at a reference value of $42.42 per unit, bringing his holdings in this plan-related instrument to 1,247.7606 phantom stock units held directly.
Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock plus a small amount of cash-equivalent investments, which typically account for around 5% of the unit’s total value. The units are settled in cash following his separation from service, and their value is determined by the market value of Zoetis common stock together with the value of the cash-equivalent investments.
Zoetis Inc. Executive Vice President Kevin Esch reported an award of cash-settled phantom stock units linked to Zoetis common stock. On 01/09/2026, he acquired 100.6422 phantom stock units at a reference value of $42.42 per unit, bringing his total to 277.038 phantom stock units.
The units were acquired under the Zoetis Supplemental Savings Plan and will be settled in cash after his separation from service. Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock plus a small portion of cash-equivalent investments, with the value determined by the market price of Zoetis stock and the value of those cash-equivalent holdings.
Zoetis Inc. Chief Financial Officer Joseph Wetteny reported acquiring 217.6054 phantom stock units on January 9, 2026 at a reference price of $42.42 per unit. After this transaction, he holds a total of 6,803.5995 phantom stock units in a company plan. These units were acquired under the Zoetis Supplemental Savings Plan and are designed to be settled in cash after his separation from service, rather than in actual Zoetis shares.
Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock plus a small cash-equivalent component, which typically makes up around 5% of the unit’s total value. The value of the units is determined by the market value of Zoetis common stock together with the value of the cash-equivalent investments, so their value moves generally in line with the stock over time.
Zoetis Inc. Executive Vice President Rimma Driscoll reported an acquisition of 141.4427 phantom stock units on January 9, 2026. These units were credited at a reference value of $42.42 per unit under the Zoetis Supplemental Savings Plan, bringing her total phantom stock unit balance to 5,367.8047 units held as a direct interest. The phantom stock units are settled in cash after her separation from service, and their value is determined by the market value of Zoetis common stock plus a small portion in cash-equivalent investments, which typically represent around 5% of each unit’s total value.
Zoetis Inc. Executive Vice President Roxanne Lagano reported acquiring 190.4046 phantom stock units on January 9, 2026, at a transaction price of $42.42 per unit. Following this transaction, she beneficially owns 28,815.1316 phantom stock units.
The units were acquired under the Zoetis Supplemental Savings Plan and are settled in cash after her separation from service. Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock plus cash-equivalent investments, which typically make up around 5% of the unit’s total value. The value of these units is determined by the market value of Zoetis common stock and the associated cash-equivalent investments.
Zoetis Inc. executive Julie Fuller reported a new grant of 190.4045 phantom stock units on January 9, 2026. The filing shows the units were acquired at a reference value of $42.42 per unit, bringing her total phantom stock unit balance to 578.0564 held directly.
These phantom stock units were acquired under the Zoetis Supplemental Savings Plan and are settled in cash after her separation from service. Each unit represents a fraction of a phantom share of Zoetis common stock plus a small cash-equivalent component, with the cash-equivalent investments typically around 5% of the unit’s total value. The value of the award therefore tracks the market value of Zoetis common stock together with the related cash-equivalent investments.
Zoetis Inc. reports insider share holdings for Executive Vice President Kevin Esch. As of the reporting date, he directly owns 267 shares of Zoetis common stock and indirectly holds 122.9323 common stock equivalents through the Zoetis Savings Plan, a 401(k) plan, as of December 31, 2025.
He also holds several equity awards: 772.2513, 306.1133, 86.8836 and 50.5137 restricted stock units that generally vest in thirds over three years from grant dates in 2023–2025, plus stock options on 1,181, 490, 545 and 391 shares at exercise prices of $156.64, $196.14, $162.07 and $201.3, typically vesting over three years and expiring ten years from grant. In addition, he holds 176.3958 phantom stock units under a supplemental savings plan that are settled in cash after separation from service.